US 10849917
Antisense-induced exon exclusion in type VII collagen
granted A61KA61K31/70A61P
Quick answer
US patent 10849917 (Antisense-induced exon exclusion in type VII collagen) held by Sarepta Therapeutics, Inc. expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/70, A61P, A61P17/00